At a glance
ClinicalIndex Comparison RecordN/ACompleted· 130 enrolled
Drug / intervention
continuous glucose monitoring systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform Based on Artificial Intelligence Model Using Mathematical Analysis
In Brief
An observational study evaluating continuous glucose monitoring system for PreDiabetes and 2 related conditions. Completed, enrolled 130 participants across 1 site.
Detailed Summary
The purpose of this study is to collect a variety of clinical data and blood glucose changes using a continuous glucose monitoring device for high-risk diabetes patients (prediabetes) in order to develop a personalized diabetes prevention and management platform based on artificial intelligence model using mathematical analysis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPreDiabetes, Glucose Metabolism Disorders, Diabetes Mellitus
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedApr 2020
Enrollment StartMay 2020
Primary CompletionSep 2020
TodayJul 2026
First PostedApr 30, 2020
Enrollment StartMay 11, 2020
Primary CompletionSep 30, 2020
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 6.2 years ago
Interventions
continuous glucose monitoring systemdevice
wearing continuous glucose monitoring device (iPro2 professional continuous glucose monitoring, MedtronicⓇ, California, USA)